{"entity":{"type":"insider","cik":"0001356090","url":"/insider/0001356090","json_url":"/insider/0001356090.json","name":"INTREXON CORP","name_source":"as-filed","also_issuer":true,"cross_url":"/issuer/0001356090"},"coverage_statement":{"n_transactions":59,"n_filings":29,"first":"2011-01-14","last":"2019-04-03","span_basis":"filed_date"},"name_variants":[{"name":"INTREXON CORP","source":"filing","n_filings":29,"first_seen":"2011-01-14","last_seen":"2019-04-03"}],"transactions":[{"id":8535458,"accession":"0001567619-19-008334","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-19-008334","line_url":"/filing/0001567619-19-008334","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95241.0,"shares_display":"95,241","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":61906.65,"total_display":"61,906.65","total_whole":"61,907","shares_owned_after":165332.0,"shares_owned_after_display":"165,332","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-03","filed_date":"2019-04-03","scope":"insider","n_lines":2},{"id":8535449,"accession":"0001567619-19-008334","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-19-008334","line_url":"/filing/0001567619-19-008334","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13646.0,"shares_display":"13,646","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":9006.36,"total_display":"9,006.36","total_whole":"9,006","shares_owned_after":234493.0,"shares_owned_after_display":"234,493","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-02","filed_date":"2019-04-03","scope":"insider","n_lines":2},{"id":8535439,"accession":"0001567619-19-008334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-008334","line_url":"/filing/0001567619-19-008334","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41678.0,"shares_display":"41,678","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":27924.26,"total_display":"27,924.26","total_whole":"27,924","shares_owned_after":244402.0,"shares_owned_after_display":"244,402","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider","n_lines":2},{"id":8686294,"accession":"0001567619-19-001160","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-19-001160","line_url":"/filing/0001567619-19-001160#line-3","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"HISTOGENICS CORP","issuer_ticker":"HSGX","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345897.0,"shares_display":"345,897","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":51884.55,"total_display":"51,884.55","total_whole":"51,885","shares_owned_after":1692366.0,"shares_owned_after_display":"1,692,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-15","filed_date":"2019-01-15","scope":"insider"},{"id":8686289,"accession":"0001567619-19-001160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-001160","line_url":"/filing/0001567619-19-001160#line-2","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"HISTOGENICS CORP","issuer_ticker":"HSGX","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400507.0,"shares_display":"400,507","price_per_share":0.16,"price_display":"0.16","price_state":"stated","total_value":64081.12,"total_display":"64,081.12","total_whole":"64,081","shares_owned_after":2038263.0,"shares_owned_after_display":"2,038,263","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-14","filed_date":"2019-01-15","scope":"insider"},{"id":8686280,"accession":"0001567619-19-001160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-001160","line_url":"/filing/0001567619-19-001160#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"HISTOGENICS CORP","issuer_ticker":"HSGX","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":251800.0,"shares_display":"251,800","price_per_share":0.17,"price_display":"0.17","price_state":"stated","total_value":42806.0,"total_display":"42,806.00","total_whole":"42,806","shares_owned_after":2438770.0,"shares_owned_after_display":"2,438,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-11","filed_date":"2019-01-15","scope":"insider"},{"id":6310317,"accession":"0001140361-18-002633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-002633","line_url":"/filing/0001140361-18-002633#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"AquaBounty Technologies, Inc.","issuer_ticker":"AQB","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1538461.0,"shares_display":"1,538,461","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":4999998.25,"total_display":"4,999,998.25","total_whole":"4,999,998","shares_owned_after":6700738.0,"shares_owned_after_display":"6,700,738","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-17","filed_date":"2018-01-19","scope":"insider"},{"id":4315549,"accession":"0001140361-17-046077","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-046077","line_url":"/filing/0001140361-17-046077","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2727273.0,"shares_display":"2,727,273","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":2100000.21,"total_display":"2,100,000.21","total_whole":"2,100,000","shares_owned_after":5773626.0,"shares_owned_after_display":"5,773,626","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-11","filed_date":"2017-12-13","scope":"insider","n_lines":3},{"id":4787899,"accession":"0001140361-17-018903","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001140361-17-018903","line_url":"/filing/0001140361-17-018903","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11576.0,"shares_display":"11,576","price_per_share":2.54,"price_display":"2.54","price_state":"stated","total_value":29403.04,"total_display":"29,403.04","total_whole":"29,403","shares_owned_after":440418.0,"shares_owned_after_display":"440,418","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-08","filed_date":"2017-05-08","scope":"insider","n_lines":2},{"id":4787891,"accession":"0001140361-17-018903","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-17-018903","line_url":"/filing/0001140361-17-018903","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85500.0,"shares_display":"85,500","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":230850.0,"total_display":"230,850.00","total_whole":"230,850","shares_owned_after":450113.0,"shares_owned_after_display":"450,113","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-05","filed_date":"2017-05-08","scope":"insider","n_lines":2},{"id":4787878,"accession":"0001140361-17-018903","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-018903","line_url":"/filing/0001140361-17-018903","is_derivative":false,"issuer_cik":"0000812796","issuer_name":"SOLIGENIX, INC.","issuer_ticker":"SNGX","issuer_name_source":null,"issuer_url":"/issuer/0000812796","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63892.0,"shares_display":"63,892","price_per_share":3.7818387278532524,"price_display":"3.78","price_state":"stated","total_value":241629.24,"total_display":"241,629.24","total_whole":"241,629","shares_owned_after":533459.0,"shares_owned_after_display":"533,459","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-04","filed_date":"2017-05-08","scope":"insider","n_lines":3},{"id":4862445,"accession":"0001140361-17-002429","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001140361-17-002429","line_url":"/filing/0001140361-17-002429#line-28","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"AquaBounty Technologies, Inc.","issuer_ticker":"AQB","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2421073.0,"shares_display":"2,421,073","price_per_share":10.33,"price_display":"10.33","price_state":"stated","total_value":25009684.09,"total_display":"25,009,684.09","total_whole":"25,009,684","shares_owned_after":5161247.0,"shares_owned_after_display":"5,161,247","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-01-18","filed_date":"2017-01-20","scope":"insider"},{"id":2332858,"accession":"0001140361-16-091123","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-16-091123","line_url":"/filing/0001140361-16-091123","is_derivative":false,"issuer_cik":"0000921114","issuer_name":"AmpliPhi Biosciences Corp","issuer_ticker":"APHB","issuer_name_source":null,"issuer_url":"/issuer/0000921114","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42000.0,"shares_display":"42,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":18900.0,"total_display":"18,900.00","total_whole":"18,900","shares_owned_after":736170.0,"shares_owned_after_display":"736,170","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-29","filed_date":"2016-12-29","scope":"insider","n_lines":2},{"id":2332849,"accession":"0001140361-16-091123","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-16-091123","line_url":"/filing/0001140361-16-091123","is_derivative":false,"issuer_cik":"0000921114","issuer_name":"AmpliPhi Biosciences Corp","issuer_ticker":"APHB","issuer_name_source":null,"issuer_url":"/issuer/0000921114","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84620.0,"shares_display":"84,620","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":39771.4,"total_display":"39,771.40","total_whole":"39,771","shares_owned_after":758093.0,"shares_owned_after_display":"758,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-28","filed_date":"2016-12-29","scope":"insider","n_lines":2},{"id":2332840,"accession":"0001140361-16-091123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-091123","line_url":"/filing/0001140361-16-091123","is_derivative":false,"issuer_cik":"0000921114","issuer_name":"AmpliPhi Biosciences Corp","issuer_ticker":"APHB","issuer_name_source":null,"issuer_url":"/issuer/0000921114","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50400.0,"shares_display":"50,400","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":25704.0,"total_display":"25,704.00","total_whole":"25,704","shares_owned_after":802263.0,"shares_owned_after_display":"802,263","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-27","filed_date":"2016-12-29","scope":"insider","n_lines":2},{"id":2216832,"accession":"0001140361-16-071479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-071479","line_url":"/filing/0001140361-16-071479#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ORAGENICS INC","issuer_ticker":"OGEN","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2261419.0,"shares_display":"2,261,419","price_per_share":0.5159,"price_display":"0.52","price_state":"stated","total_value":1166666.0621,"total_display":"1,166,666.06","total_whole":"1,166,666","shares_owned_after":14481089.0,"shares_owned_after_display":"14,481,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-30","filed_date":"2016-07-05","scope":"insider"},{"id":8755084,"accession":"0001140361-15-034452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-034452","line_url":"/filing/0001140361-15-034452#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":937500.0,"shares_display":"937,500","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":9613268.0,"shares_owned_after_display":"9,613,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-02","filed_date":"2015-09-04","scope":"insider"},{"id":8448077,"accession":"0001140361-15-028723","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-028723","line_url":"/filing/0001140361-15-028723","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":975987.0,"shares_display":"975,987","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":5660724.6,"total_display":"5,660,724.60","total_whole":"5,660,725","shares_owned_after":582116.0,"shares_owned_after_display":"582,116","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-27","filed_date":"2015-07-27","scope":"insider","n_lines":3},{"id":8250609,"accession":"0001140361-15-012497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-012497","line_url":"/filing/0001140361-15-012497#line-1","is_derivative":false,"issuer_cik":"0000921114","issuer_name":"AmpliPhi Biosciences Corp","issuer_ticker":"APHB","issuer_name_source":null,"issuer_url":"/issuer/0000921114","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13939392.0,"shares_display":"13,939,392","price_per_share":0.165,"price_display":"0.16","price_state":"stated","total_value":2299999.68,"total_display":"2,299,999.68","total_whole":"2,300,000","shares_owned_after":37939392.0,"shares_owned_after_display":"37,939,392","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-18","scope":"insider"},{"id":8923878,"accession":"0001140361-15-005105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-005105","line_url":"/filing/0001140361-15-005105#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1440000.0,"shares_display":"1,440,000","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":12600000.0,"total_display":"12,600,000.00","total_whole":"12,600,000","shares_owned_after":17830305.0,"shares_owned_after_display":"17,830,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-10","scope":"insider"},{"id":7001886,"accession":"0001140361-14-024707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-024707","line_url":"/filing/0001140361-14-024707#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":2.9,"price_display":"2.90","price_state":"stated","total_value":1160000.0,"total_display":"1,160,000.00","total_whole":"1,160,000","shares_owned_after":9619512.0,"shares_owned_after_display":"9,619,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-04","filed_date":"2014-06-06","scope":"insider"},{"id":6634724,"accession":"0001140361-14-003401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-003401","line_url":"/filing/0001140361-14-003401#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1024590.0,"shares_display":"1,024,590","price_per_share":4.88,"price_display":"4.88","price_state":"stated","total_value":4999999.2,"total_display":"4,999,999.20","total_whole":"4,999,999","shares_owned_after":6024915.0,"shares_owned_after_display":"6,024,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-24","filed_date":"2014-01-28","scope":"insider"},{"id":5131276,"accession":"0001140361-13-047006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-047006","line_url":"/filing/0001140361-13-047006","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500000.0,"shares_display":"2,500,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":2500000.0,"total_display":"2,500,000.00","total_whole":"2,500,000","shares_owned_after":8675768.0,"shares_owned_after_display":"8,675,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-12-17","filed_date":"2013-12-19","scope":"insider","n_lines":2},{"id":4651837,"accession":"0001140361-13-043957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-043957","line_url":"/filing/0001140361-13-043957","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ORAGENICS INC","issuer_ticker":"OGEN","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1242490.0,"shares_display":"1,242,490","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":3106225.0,"total_display":"3,106,225.00","total_whole":"3,106,225","shares_owned_after":8140425.0,"shares_owned_after_display":"8,140,425","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-20","filed_date":"2013-11-22","scope":"insider","n_lines":2},{"id":5130778,"accession":"0001140361-13-040086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-040086","line_url":"/filing/0001140361-13-040086#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2857143.0,"shares_display":"2,857,143","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":10000000.5,"total_display":"10,000,000.50","total_whole":"10,000,001","shares_owned_after":16390305.0,"shares_owned_after_display":"16,390,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-10-31","scope":"insider"},{"id":5502162,"accession":"0001140361-13-037699","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-13-037699","line_url":"/filing/0001140361-13-037699","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3658536.0,"shares_display":"3,658,536","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":14999997.6,"total_display":"14,999,997.60","total_whole":"14,999,998","shares_owned_after":5000325.0,"shares_owned_after_display":"5,000,325","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-01","filed_date":"2013-10-03","scope":"insider","n_lines":2},{"id":5234315,"accession":"0001140361-13-037608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-037608","line_url":"/filing/0001140361-13-037608#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ORAGENICS INC","issuer_ticker":"OGEN","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2648510.0,"shares_display":"2,648,510","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":7945530.0,"total_display":"7,945,530.00","total_whole":"7,945,530","shares_owned_after":7040935.0,"shares_owned_after_display":"7,040,935","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-30","filed_date":"2013-10-02","scope":"insider"},{"id":4650439,"accession":"0001140361-13-029527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-13-029527","line_url":"/filing/0001140361-13-029527#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1243781.0,"shares_display":"1,243,781","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":7499999.43,"total_display":"7,499,999.43","total_whole":"7,499,999","shares_owned_after":2561301.0,"shares_owned_after_display":"2,561,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-26","filed_date":"2013-07-30","scope":"insider"},{"id":3074442,"accession":"0001140361-12-046492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-046492","line_url":"/filing/0001140361-12-046492#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3636926.0,"shares_display":"3,636,926","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":13533162.0,"shares_owned_after_display":"13,533,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-11-07","filed_date":"2012-11-09","scope":"insider"},{"id":2787949,"accession":"0001140361-12-045067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-045067","line_url":"/filing/0001140361-12-045067#line-1","is_derivative":false,"issuer_cik":"0000894158","issuer_name":"Synthetic Biologics, Inc.","issuer_ticker":"SYN","issuer_name_source":null,"issuer_url":"/issuer/0000894158","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3125000.0,"shares_display":"3,125,000","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":3125000.0,"shares_owned_after_display":"3,125,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-10-29","filed_date":"2012-10-31","scope":"insider"},{"id":3286804,"accession":"0001140361-12-034892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-034892","line_url":"/filing/0001140361-12-034892#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ORAGENICS INC","issuer_ticker":"ORNI","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":857555.0,"shares_display":"857,555","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":1286332.5,"total_display":"1,286,332.50","total_whole":"1,286,333","shares_owned_after":857555.0,"shares_owned_after_display":"857,555","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-31","filed_date":"2012-08-02","scope":"insider"},{"id":3284752,"accession":"0001140361-12-003409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-003409","line_url":"/filing/0001140361-12-003409#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"KIRK RANDAL J; INTREXON CORP","owner_display_name":"KIRK RANDAL J","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1923075.0,"shares_display":"1,923,075","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":9896236.0,"shares_owned_after_display":"9,896,236","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-20","filed_date":"2012-01-23","scope":"insider"},{"id":9086879,"accession":"0001140361-11-043686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-043686","line_url":"/filing/0001140361-11-043686#line-1","is_derivative":false,"issuer_cik":"0001091823","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001091823","owner_cik":null,"owner_name":"INTREXON CORP; KIRK RANDAL J","owner_display_name":"INTREXON CORP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38294.0,"shares_display":"38,294","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":191087.06,"total_display":"191,087.06","total_whole":"191,087","shares_owned_after":1346462.0,"shares_owned_after_display":"1,346,462","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-23","filed_date":"2011-08-25","scope":"insider"}],"collapsed":true,"next_cursor":"2011-08-23|9086879","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000894158","name":"Synthetic Biologics, Inc.","url":"/issuer/0000894158","role":"Ten percent owner","n_filings":4,"first_seen":"2012-10-31","last_seen":"2019-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001372299","name":"HISTOGENICS CORP","url":"/issuer/0001372299","role":"Ten percent owner","n_filings":1,"first_seen":"2019-01-15","last_seen":"2019-01-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001603978","name":"AquaBounty Technologies, Inc.","url":"/issuer/0001603978","role":"Ten percent owner","n_filings":2,"first_seen":"2017-01-20","last_seen":"2018-01-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000357097","name":"Fibrocell Science, Inc.","url":"/issuer/0000357097","role":"Ten percent owner","n_filings":6,"first_seen":"2013-07-30","last_seen":"2017-12-13"},{"type":"issuer","type_label":"ISSUER","cik":"0000812796","name":"SOLIGENIX, INC.","url":"/issuer/0000812796","role":"Ten percent owner","n_filings":1,"first_seen":"2017-05-08","last_seen":"2017-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000921114","name":"AmpliPhi Biosciences Corp","url":"/issuer/0000921114","role":"Ten percent owner","n_filings":2,"first_seen":"2015-03-18","last_seen":"2016-12-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001174940","name":"ORAGENICS INC","url":"/issuer/0001174940","role":"Ten percent owner","n_filings":4,"first_seen":"2012-08-02","last_seen":"2016-07-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001107421","name":"ZIOPHARM ONCOLOGY INC","url":"/issuer/0001107421","role":"Ten percent owner","n_filings":9,"first_seen":"2011-01-14","last_seen":"2015-02-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001356090","retrieved_at":"2026-08-26T01:52:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}